Friday, November 13, 2026

Dollar Falls to 2022 Lows as Euro Gains 14%, Pound Up 7% in Global Currency Shift

The US dollar hit its weakest level since 2022 as the Euro surged 14% and the British Pound gained 7% through 2025. Uncertainty over Federal Reserve leadership transition and easing geopolitical tensions drove global investors away from dollar-denominated assets.

ViaNews Editorial Team

February 25, 2026

Source Trace Score3 source documents3 with a live linkVerifiability: Strong
Dollar Falls to 2022 Lows as Euro Gains 14%, Pound Up 7% in Global Currency Shift
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

The US dollar dropped to its lowest point since 2022, with the Euro climbing 14% and the British Pound advancing 7% against the greenback through 2025. Global currency markets shifted as investors rotated away from dollar assets ahead of Federal Reserve Chair Jerome Powell's June 2026 departure.

The dollar's decline accelerated as Iran-US nuclear negotiations progressed, reducing risk premiums that previously supported the currency. European Central Bank policy divergence further boosted Euro demand, while Sterling strengthened despite domestic UK pressures.

The Pound traded at $1.3086, though analysts warned gains may reverse. Jordan Rochester at Mizuho Bank said "GBP could fall below $1.30" as the UK government prepares tax increases in its November 26 Budget. UK 30-year gilt yields reached 5.21%, the highest since August 1998, as inflation concerns mounted.

Against the Euro, Sterling fell 0.4% to €1.13, its weakest level since April 2023. The cross-currency move reflected broader European strength rather than UK-specific weakness. Simon Phillips at No1 Currency noted mounting pressure on the Pound despite year-to-date gains.

Currency traders positioned for continued dollar weakness through 2026, though some analysts believe the decline nears technical limits. The Euro-dollar and Cable (GBP/USD) pairs captured most flows from greenback selling. Neil Wilson at Saxo Markets highlighted fiscal instability risks across major economies as investors reassess currency allocations.

Markets now watch Fed communications and UK fiscal policy for direction. The leadership transition at the world's most influential central bank creates uncertainty for global monetary policy coordination. Currency analysts see the Fed chair changeover as a pivotal moment for international currency markets.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score3 source documents3 with a live linkVerifiability: Strong
  1. [1]News articleUk· November 12, 2025
    Pound hits two-year low against euro as Starmer under fire
  2. [2]News articleYahoo Finance· December 31, 2025
    Stock market today: Dow, S&P 500, Nasdaq post double-digit gains in 2025 as AI trade powers market once again
  3. [3]News articleYahoo Finance· February 17, 2026
    Stock market today: Dow, S&P 500, Nasdaq waver in volatile trading as AI anxiety lingers

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com